MedTech Dive · Jul 1, 2026
FDA authorizes more devices so far in 2026, but it’s taking longer
Original premarket approvals are taking “substantially longer” than last year, according to a report from BTIG.
Latest medical news · page 118
The latest headlines across every section, pulled from official and open-access sources.
ACP · Jul 1, 2026
ACP calls for increased oversight of private equity and corporatization in healthcare
New policy paper outlines recommendations to strengthen oversight and transparency of private equity and corporatization in healthcare and their effects on clinical autonomy and care delivery.
MedCity News · Jul 1, 2026
MedCity FemFwd: Inside Winona’s New Women’s Health Research Initiative
In this episode, we’re joined by Dr. Cathleen Brown, medical director of menopause company Winona. We discuss the company’s new Winona Research Initiative, which seeks to fund and support menopause and women’s health research. The post MedCity FemFwd: Inside Winona’s New Women’s Health Research Initiative appeared first on MedCity News .
ACC (Cardiology) · Jul 1, 2026
Novel Sarcopenic Obesity Index Predicts CV Risk
A novel sarcopenic obesity index served as a clinically meaningful predictor of cardiovascular risk and lent further insight into accompanying genetics and possible therapeutic targets, according to research published July 1 in JACC.
Fierce Biotech · Jul 1, 2026
Merck halts ph. 2 Alzheimer’s trial after Neuphoria small molecule underwhelms
Merck & Co. has nixed the phase 2 study of a potential Alzheimer’s disease medicine after the drug underwhelmed in an interim analysis, marking another blow for the pharma’s struggling partner Neuphoria Therapeutics.
Fierce Biotech · Jul 1, 2026
Insilico keeps partnership sprint apace in $600M biobucks collab with Takeda
Insilico Medicine has signed a deal worth up to $600 million with Japanese Big Pharma Takeda to collaborate on discovery of assets across Takeda’s therapeutic areas of interest.
MHRA (UK) · Jul 1, 2026
Medicines: packaging, labelling and patient information leaflets
How to package medicines for sale and what information you must provide to consumers and healthcare professionals.
MHRA (UK) · Jul 1, 2026
Guidance: Warning statements for labels and leaflets of certain medicines
This guidance sets out the warning statements which should appear on the label and/or in the leaflet of certain medicines.
MHRA (UK) · Jul 1, 2026
Guidance: Best practice guidance on patient information leaflets
This guidance sets out the legal framework for patient information leaflets as described in EU and national legislation and best practice in the area of information design.
ACC (Cardiology) · Jul 1, 2026
Poll Results: Brainstorm: Restarting Anticoagulation After Brain Bleed
This poll included a clinical vignette of an 80-year-old man with atrial fibrillation (AF), high thromboembolic risk, and multiple cardiovascular (CV) comorbidities who presented 2 months after a spontaneous lobar intracerebral hemorrhage while receiving reduced-dose apixaban...
MedCity News · Jul 1, 2026
Your Healthcare AI Strategy Is Probably an Architecture Problem
These three patterns keep showing up, and each is much cheaper to prevent than to fix later. The post Your Healthcare AI Strategy Is Probably an Architecture Problem appeared first on MedCity News .
MHRA (UK) · Jul 1, 2026
MHRA authorises gemcitabine delivery system for adults with BCG-unresponsive high-risk non-muscle invasive bladder cancer
As with any medicinal product, the MHRA will keep the safety and effectiveness of the intravesical delivery system containing gemcitabine under close review.
BMJ Open · Jul 1, 2026
Improving communication of prognostic uncertainty in advanced illness: a realist review
Objectives Prognostic uncertainty is common in advanced illness, driven by multimorbidity, treatment complexities and unpredictable disease trajectories. When inadequately acknowledged or discussed, it can lead to patient and family distress and inhibit decision-making. We aimed to build a programme theory of how, why and for whom communication of prognostic uncertainty ‘works’ (or not) in advanced illness and palliative care contexts. Design Realist systematic review, reported according to RAMESES criteria. Data sources Embase, MEDLINE, CINAHL, Cochrane Database of Systematic Reviews, SCI via…
MedCity News · Jul 1, 2026
Healthcare Retention Depends On Better Pathways, Not Just Better Pay
When workers feel stuck in place, with limited opportunities to advance or deepen their skills, disengagement tends to follow. In allied health roles, where burnout is already high and many touch the patient experience, it is a risk healthcare employers cannot afford to ignore. The post Healthcare Retention Depends On Better Pathways, Not Just Better Pay appeared first on MedCity News .
MedCity News · Jul 1, 2026
What Healthcare Leaders Should Know Before Implementing AI-Powered Documentation Tools
These tools are worth implementing. They are not worth implementing without the right preparation. The post What Healthcare Leaders Should Know Before Implementing AI-Powered Documentation Tools appeared first on MedCity News .
ACC (Cardiology) · Jul 1, 2026
Eagle’s Eye View: Clopidogrel vs. Aspirin Following PCI
In this week’s View, Dr. Eagle looks at how genotype independently predicts heart failure outcomes in patients with hypertrophic cardiomyopathy (HCM).
FDA Drugs · Jul 1, 2026
Submitting Next-Generation Sequencing Data to the Division of Antiviral Products
Electronic Submissions and Clinical/Antimicrobial.
ACC (Cardiology) · Jul 1, 2026
Guest Editorial | Turning Prevention Into Practice: ACC's Coordinated Approach
The ACC's work in cardiovascular disease (CVD) prevention is entering an important new phase – one that reflects both the urgency of the challenge and the opportunity to deliver lasting impact.
ACC (Cardiology) · Jul 1, 2026
Cover Story | Integrating Heart-Healthy Nutrition Into Everyday Cardiology Care
Hippocrates is often credited with saying, "Let food be thy medicine, and medicine be thy food." Now, modern day research is proving there is truth to this ancient wisdom.
ACC (Cardiology) · Jul 1, 2026
New in Clinical Guidance | Postpartum CV Care
A new ACC Expert Consensus Decision Pathway (ECDP) addressing "Optimization of Postpartum Care for Patients With and at Risk for Premature and Long-Term Cardiovascular (CV) Disease" provides recommended strategies for successful postpartum cardiovascular care...
ACC (Cardiology) · Jul 1, 2026
Peripheral Matters | Catheter-Based Intervention in Intermediate-Risk PE
Until the ACC/AHA guideline on the management of acute pulmonary embolism (PE) was published in February, more than a decade had passed since the last one. During this interval, catheter-based interventions have expanded substantially, reshaping management of intermediate-risk PE.
ACC (Cardiology) · Jul 1, 2026
Cutting-Edge Structural Interventions | Transcatheter Treatment of Mitral Annular Calcification: Where Do We Stand?
Mitral annular calcification (MAC), which can produce mitral regurgitation (MR), mitral stenosis or both, is among the most challenging conditions to manage in cardiovascular medicine due to anatomic and patient complexity.
ACC (Cardiology) · Jul 1, 2026
Online Exclusive | SCAI 2026 Roundup: Major Coronary, Structural and Vascular Trials From Montréal
The 2026 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions and CAIC-ACCI Summit, held in Montréal, Canada, highlighted the continuing evolution of interventional cardiology through the presentation of several important late-breaking clinical trials.
ACC (Cardiology) · Jul 1, 2026
Focus on EP | 3 Meetings, 5 Trends Impacting EP Practice
Cardiac electrophysiology (EP) is evolving quickly and data presented this year at ACC.26, European Heart Rhythm Association (EHRA 2026) and Heart Rhythm Society (HRS 2026) suggest practice may change just as fast.